Browse All

Current Filters

CLEAR FILTER x

TITLE

Relapsing CNS-restricted Autoinflammatory Demyelination Due to Complement Factor I Deficiency: A Diagnostic Odyssey in Seronegative Neuroinflammation

Real-world Clinical Outcomes with Eculizumab and Ravulizumab in Anti–Aquaporin-4 Antibody–Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results From the Global NMO SPOTLIGHT Registry

2025 U.S. Update of Meningococcal Infection Incidence & Outcomes in Eculizumab or Ravulizumab Patients with Generalized Myasthenia Gravis or Neuromyelitis Optica Spectrum Disorder in Clinical Practice